Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Emraclidine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bristol’ schizophrenia drug nears approval, AbbVie hope to provide competition
    Bristol’ schizophrenia drug nears approval, AbbVie hope to provide competition

    19 Aug 2024

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/bms-karxt-schizophrenia-approval-abbvie/724555/

    BIOPHARMADIVE
    19 Aug 2024
    Share Share
    AbbVie Completes Acquisition of Cerevel Therapeutics
    AbbVie Completes Acquisition of Cerevel Therapeutics

    01 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbvie-completes-acquisition-of-cerevel-therapeutics-302212336.html

    PR NEWSWIRE
    01 Aug 2024
    Share Share
    AbbVie to acquire Cerevel for $8.7 billion
    AbbVie to acquire Cerevel for $8.7 billion

    07 Dec 2023

    // Ananya M. Rajesh REUTERS

    https://www.reuters.com/markets/deals/abbvie-buy-drug-developer-cerevel-87-billion-2023-12-06/

    Ananya M. Rajesh REUTERS
    07 Dec 2023
    Share Share